Statement Re: Foot & Mouth

Genus PLC
06 August 2007


For Immediate Release                                             6 August 2007


                                   Genus Plc


Genus, the leading multi species global genetics company makes the following
statement in relation to the case of foot and mouth disease confirmed in GB last
Friday evening.


There is no measurable impact upon our business.

The ravaging 2001 outbreak had no adverse impact on the business. Since that
time Genus has developed both geographically and in species. Currently, only 14%
of company turnover is in GB animal related business.

All of Genus' GB breeding stock facilities are located far from the source of
the outbreak. Nevertheless, we have further enhanced our already high
bio-security procedures.

The Board will keep the situation under constant review and will make a further
announcement if the situation changes from that described above

For further information, please contact:


Genus Plc                                  Tel: [phone]
Martin Boden, Finance Director

Buchanan Communications                    Tel: [phone]
Charles Ryland / Suzanne Brocks

Bridgewell Securities Ltd
Fred Ward / Shaun Dobson                   Tel: [phone].






                      This information is provided by RNS
            The company news service from the London Stock Exchange